Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-436-5 | CAS number: 13076-17-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
L-lactide (purity 99 %) was tested negative for skin sensitisation properties in a study conducted according to OECD 429. L-lactide is the enantiomer of D-lactide and therefore a suitable read-across partner.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- For details and justification of read-across please refer to the read-across report attached to IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Positive control results:
- The six-month reliability check with alpha-hexylcinnamicaldehyde indicates that the Local Lymph Node Assay as performed at NOTOX is an appropriate model for testing for contact hypersensitivity.
The SI values calculated for alpha-hexylcinnamicaldehyde concentrations 5, 10 and 25% were 1.7, 2.7 and 8.8 respectively. An EC3 value of 10.7% was calculated using linear interpolation. The calculated EC3 value was found to be in the acceptable range of 2 and 20%. - Parameter:
- SI
- Value:
- 2.1
- Test group / Remarks:
- low dose (10% test substance)
- Parameter:
- SI
- Value:
- 1.5
- Test group / Remarks:
- mid-dose (25% test substance)
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- high-dose (50% test substance)
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION:
The SI values calculated for the substance concentrations 10, 25 and 50% were 2.1, 1.5 and 0.9, respectively. Since there was no indication that the test substance elicit an SI ≥ 3 when tested up to 50%, L-lactide was considered not to be a skin sensitizer. It was established that the EC3 value (the estimated test substance concentration that will give a SI=3) (if any) exceeds 50%. See Table 2 below.
CLINICAL OBSERVATIONS:
No irritation of the ears was observed in any of the animals examined. White remnants of the test substance were present on the ears at the 50% concentration, but this did not hamper the scoring of erythema. All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. Red discolouration of the left auricular lymph node was noted for one male (no. 12) at 25%. No macroscopic abnormalities of the surrounding area were noted in any of the animals.
BODY WEIGHTS:
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. The slight body weight loss, noted in some animals, was considered not toxicologically significant.
SIGNS OF TOXICITY (including dermal irritation at the site of administration, if any, e.g. increased ear thickness):
No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results derived from in a mouse local lymph node assay, L-lactide is considered not to be a skin sensitizer.
- Executive summary:
In a dermal senisitization study with L-lactide (purity 99%) in dimethyl formamide, young adult CBA/J mice (5 females/group) were tested (0, 10, 25 and 50% substance concentration) according to OECD 429 (LLNA). As positive control material alpha-hexylcinnamicaldehyde was used. No irritation of the ears was observed in any of the animals examined. Red discouloration of the left auricular lymph node was noted for one male in the 25% treatment group. All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted in any of the animals. No mortality occurred and no symptoms of systemic toxicity were observed in the animals.
The SI values calculated for the substance concentrations 10, 25 and 50% were 2.1, 1.5 and 0.9 respectively. Since there was no indication that the test substance elicits an SI≥ 3 when tested up to 50%, L-lactide was considered not to be a skin sensitizer.
This information is used in a read-across approach in the assessment of the target substance. For details and justification of read-across please refer to the read-across report attached to IUCLID section 13.
Reference
Table 1: Radioactivity measurements (individual animals)
group |
Test substance1 (% w/w) |
animal |
DPM/animal |
|
|
|
|
1 |
0% (vehicle) |
1 |
481 |
2 |
378 |
||
3 |
391 |
||
4 |
273 |
||
5 |
379 |
||
|
|
|
|
2 |
10% |
6 |
681 |
7 |
1173 |
||
8 |
381 |
||
9 |
786 |
||
10 |
914 |
||
|
|
|
|
3 |
25% |
11 |
524 |
12 |
366 |
||
13 |
842 |
||
14 |
707 |
||
15 |
405 |
||
|
|
|
|
4 |
50% |
16 |
324 |
17 |
207 |
||
18 |
426 |
||
19 |
501 |
||
20 |
211 |
1Vehicle: Dimethyl formamide.
Table 2: Disintegration Per Minute (DPM) and Stimulation Index (SI)
group |
test substance1 (% w/w) |
median DPM ± SEM |
SI ± SEM |
2 |
10% |
787 ± 131 |
2.1 ± 0.4 |
3 |
25% |
569 ± 90 |
1.5 ± 0.3 |
4 |
50% |
334 ± 58 |
0.9 ± 0.2 |
|
|
|
|
1 |
0% (vehicle) |
380 ± 33 |
1.0 ± 0.1 |
1Vehicle: Dimethyl formamide.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Only data from L-lactide is available. L-lactide is the enantiomer of D-lactide and therefore suitable as read-across partner.
In a dermal sensitization study conducted according to OECD 429 (LLNA), mice were tested negative for L-lactide (purity 99%) at 0, 10, 25 and 50% substance concentration. Based on the results from the read across partner L-lactide, D-lactide can be considered to be non-sensitizing.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data from a suitable read-across partner, D-lactide is considered to be non-sensitising and classification of D-lactide for skin sensitisation is not warranted according to CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.